Ex parte BASHKIN et al. - Page 2




          Appeal No. 1995-1304                                                         
          Application No. 07/947,071                                                   


               This appeal was taken from the examiner's decision                      
          rejecting claims 1, 3 through 8, 10 through 16, 20 through 23,               
          and 25 through 30.  Claims 31 through 33, which are the only                 
          other claims remaining in the application, stand allowed.                    


                                 REPRESENTATIVE CLAIM                                  
               Claim 1, which is illustrative of the subject matter on                 
          appeal, reads as follows:                                                    
               1.  The method of hydrolytically cleaving RNA under                     
          physiologically relevant conditions with a compound selected                 
          from the group consisting of nucleosides, nucleotides and                    
          oligodeoxy-nucleotides having attached thereto a metal complex               
          effective for RNA hydrolysis.                                                


                                    THE REJECTIONS                                     
               In rejecting the appealed claims on non-prior art                       
          grounds, the examiner does not rely on any references.                       
               The claims stand rejected as follows:  (1) claims 1, 3                  
          through 8, 10 through 16, 20 through 23, and 25 through 30                   
          under 35 U.S.C. § 112, first paragraph, "as being based on an                
          insufficient disclosure to support the scope of the claimed                  
          subject matter"; and (2) claims 1, 3 through 8, 10 through 16,               
          20 through 23, and 25 through 30 under 35 U.S.C. § 112, first                

                                         -2-                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007